Investors
| Neopec's commercial strategy is founded on the science generated by the O'Brien Institute (OBI) and the University of Melbourne. Both organisations have over 10 years of peer-reviewed publications in the areas of adipose tissue engineering and biomaterials manufacture respectively. Work at the O'Brien has resulted in a patent family on the use of fabricated chambers to promote tissue regeneration. |